IP
HAE icon

Isthmus Partners’s Haemonetics HAE Stock Holding History

Isthmus Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.95M Buy
65,951
+722
+1% +$46.4K 0.48% 57
2026
Q1 		$3.68M Sell
65,229
-2,381
-4% -$155K 0.39% 64
2025
Q4 		$5.42M Buy
67,610
+5,908
+10% +$397K 0.6% 47
2025
Q3 		$3.01M Buy
61,702
+16,505
+37% +$1.02M 0.67% 41
2025
Q2 		$3.37M Buy
45,197
+2,732
+6% +$181K 0.39% 71
2025
Q1 		$2.7M Buy
42,465
+2,245
+6% +$153K 0.34% 74
2024
Q4 		$3.14M Buy
40,220
+450
+1% +$36.1K 0.38% 70
2024
Q3 		$3.2M Sell
39,770
-8,326
-17% -$673K 0.38% 68
2024
Q2 		$3.98M Buy
48,096
+58
+0.1% +$5.1K 0.47% 61
2024
Q1 		$4.1M Buy
48,038
+30,150
+169% +$2.37M 0.47% 61
2023
Q4 		$1.53M Buy
+17,888
New +$1.55M 0.2% 102
2016
Q1 		– Sell
-13,300
Closed -$429K – 247
2015
Q4 		$429K Buy
13,300
+1,056
+9% +$34.3K 0.15% 108
2015
Q3 		$396K Buy
12,244
+305
+3% +$11.5K 0.15% 103
2015
Q2 		$494K Buy
11,939
+634
+6% +$26.7K 0.16% 100
2015
Q1 		$508K Buy
11,305
+446
+4% +$18.6K 0.17% 89
2014
Q4 		$406K Buy
+10,859
New +$398K 0.14% 105

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Isthmus Partners's HAE Position: Q2 2026 in Review

Isthmus Partners increased its Haemonetics (HAE) stake by 1.1% in Q2 2026, buying an estimated $46.4K and bringing the position to 65,951 shares worth $4.95M. The position accounts for 0.48% of the portfolio, ranked #57.

Isthmus Partners first reported a position in HAE in Q4 2014 and has held it in 16 quarters since. The position peaked at $5.42M in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Isthmus Partners held 65,951 shares of Haemonetics worth $4.95M as of Q2 2026.
  • Isthmus Partners bought 722 Haemonetics shares in Q2 2026, an estimated $46.4K.
  • Haemonetics made up 0.48% of Isthmus Partners's portfolio in Q2 2026, its #57 holding.
  • Isthmus Partners first reported a position in Haemonetics in Q4 2014 and has held it in 16 quarters since.
  • Isthmus Partners's Haemonetics position peaked at $5.42M in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.